Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Cefoperazone Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 227Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Fresenius Kabi Anti-Infectives
    Italy
    		 FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi IT R1-CEP 2003-277 - Rev 04 Cefoperazone sodium, Sterile 2021-02-10 Withdrawn by Holder Chemical 2023-02-13 1404
    28/10/2024 Qilu Antibiotics Pharmaceutical Co., Ltd.
    China
    		 Qilu Antibiotics Pharmaceutical Co., Ltd. Jinan CN CEP 2007-202 - Rev 04 Cefoperazone sodium, Sterile 2024-04-24 Valid Chemical 1404